Attached files
file | filename |
---|---|
EX-31.2 - EX-31.2 - Spero Therapeutics, Inc. | spro-ex312_6.htm |
EX-31.1 - EX-31.1 - Spero Therapeutics, Inc. | spro-ex311_14.htm |
EX-23.1 - EX-23.1 - Spero Therapeutics, Inc. | spro-ex231_7.htm |
EX-10.28 - EX-10.28 - Spero Therapeutics, Inc. | spro-ex1028_438.htm |
EX-10.25 - EX-10.25 - Spero Therapeutics, Inc. | spro-ex1025_149.htm |
EX-10.13 - EX-10.13 - Spero Therapeutics, Inc. | spro-ex1013_147.htm |
EX-10.8 - EX-10.8 - Spero Therapeutics, Inc. | spro-ex108_148.htm |
10-K - 10-K - Spero Therapeutics, Inc. | spro-10k_20201231.htm |
Exhibit 32
CERTIFICATIONS UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Spero Therapeutics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report for the year ended December 31, 2020 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Dated: March 11, 2021 |
/s/ Ankit Mahadevia, M.D. |
|
Ankit Mahadevia, M.D. |
|
|
President and Chief Executive Officer |
|
|
(Principal Executive Officer) |
|
|
|
|
|
|
|
Dated: March 11, 2021 |
/s/ Satyavrat Shukla |
|
Satyavrat Shukla |
|
|
Chief Financial Officer and Treasurer |
|
|
(Principal Financial Officer and Principal Accounting Officer) |